Treatment for vaginal dryness, thinning skin, itchiness, painful sex, frequent UTIs, and urgency.
If you’re going through menopause or well beyond it, you may be experiencing firsthand the effects of lower levels of the hormone estrogen. Vaginal dryness, pain, UTIs, and urgency are all hallmark symptoms of menopause due to low estrogen.
Adding estrogen back to the vulva and vagina can not only bring relief - it can help protect your long-term health and quality of life.
And while a trusted medical provider may have prescribed vaginal estrogen to help treat and prevent your symptoms, you may still have questions about its safety. That’s because what your doctor explained to you might differ from the information you’re reading in the boxed instructions.
In this article, we will dive into the literature, research, and expert opinions on vaginal estrogen so that you can feel informed and educated about your treatment options.
When you open your box of vaginal estrogen, you’ll read an FDA-warning label that says estrogens can increase your risk of cancer and heart disease1.
The warning label is based on evidence from a 2002 clinical study of oral estrogen. Importantly, oral estrogen is prescribed in higher doses, while vaginal estrogen is prescribed in lower doses.
Now it’s nearly twenty years later, and more research has been done on vaginal estrogen.
In 2018, two large analyses were published that support the safety of vaginal estrogen. Both analyses concluded there is no evidence that vaginal estrogen increases the risk of cancer and heart disease2,3.
Given the current science, medical practitioners worry that the FDA warning label on vaginal estrogen unnecessarily frightens women. The Menopause Society, for example, has been lobbying the FDA to change the warning label to enhance safety and emphasize the key information that women need to know about vaginal estrogen.
When considering treatments for vaginal and urinary health in menopause, it’s key to understand that there are two main types of menopause hormone therapy:
Systemic hormones are absorbed in the bloodstream and can circulate throughout the entire body - which explains the potential health risks. But vaginal estrogen is applied only to affected areas and generally does not elevate blood estrogen levels beyond what’s considered normal for postmenopausal women4,5.
Brand name | Does data show blood estrogen levels are within normal range? |
Estrace vaginal cream | |
Premarin vaginal cream | |
Yuvafem or Vagifem vaginal insert | |
Estring vaginal ring |
While there are possible health risks associated with systemic hormones, the expert opinion of The Menopause Society is that these risks are unlikely when using vaginal estrogen, since there is minimal absorption in the bloodstream.
Large amounts of clinical data point toward the safety of vaginal estrogen. For example, two large analyses concluded that vaginal estrogen is not shown to increase risk of cancer or heart disease.
According to a 2018 analysis of data from the WHI Observational Study, there was no difference in health risks between people who used vaginal estrogen and people who did not3. The findings are consistent with a 2018 analysis of clinical data from another large study called The Nurses’ Health Study.
Risk of stroke | |
Risk of invasive breast cancer | |
Risk of colorectal cancer | |
Risk of endometrial cancer | |
Risk of pulmonary embolism/deep vein thrombosis | |
Risk of coronary heart disease | |
Risk of fracture | |
Risk of all-cause mortality | |
Risk of GIE |
Clinical data shows that vaginal estrogen is not associated with endometrial cancer. But the endometrial safety is not studied in clinical trials beyond one year.
The Menopause Society states that while there is reassuring evidence that vaginal estrogen is not associated with an increased risk of endometrial cancer, more research is needed regarding long-term use.4
Regardless of whether you are taking vaginal estrogen, endometrial cancer is rare. But here are some general guidelines:
According to a 2021 expert opinion from the American College of Gynecologists published in 2021, women with a history of breast cancer may consider using vaginal estrogen at the lowest effective dose if non-hormonal treatments are not adequate to address symptoms.
However, if you wish to try vaginal estrogen, clear it with your oncologist first. Before your appointment, you should prepare to communicate your values, preferences, and symptom severity and then seek to understand the potential risks in your unique case.
Side effects associated with the use of vaginal estrogen include vaginal discharge, yeast infection, vaginal bleeding, and breast pain. If you’re experiencing unintended side effects, or if there’s something else, talk to a trusted medical provider. Some side effects may be caused by variations in formulation or dosage. Your provider may be able to help make adjustments.
While the latest scientific research points to the safety of vaginal estrogen, the information on the product label can understandably cause confusion or fear. Therefore, discussing your symptoms and goals with a trusted medical provider is key.
When it comes to treating vaginal and urinary symptoms from menopause, you have options.
Vaginal and urinary symptoms do not get better with time. By taking action now, you can prevent issues like urgency, dryness, and UTIs from worsening. At Interlude, we want you to feel safe and educated about your treatment options. Sexual health is such an important and private topic. We’re making it more approachable so that more women can live pain-free.
Interlude offers online treatment and support for menopause-related symptoms. Women can access a provider that acknowledges the importance and safety of prescription treatment, feel comfortable talking about private topics, and get ongoing treatment delivered.